- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05547594
Prehabilitation in Patients With Cancer and Type 2 Diabetes
Impact of a Multimodal Prehabilitation Programme on Markers of Health, Quality of Life and the Short and Long Post-surgery Recovery Period in Cancer Patients With Type 2 Diabetes
Surgical prehabilitation refers to pre-operative interventions aimed at increasing patients' physiological reserve so that they can better cope with the stress of surgery, avoid post-operative complications and have a faster recovery after surgery. Multimodal prehabilitation combines different aspects related to a healthy lifestyle including but not limited to; physical activity, nutritional education, anxiety coping strategies, alcohol moderation and smoking cessation. Although these aspects are well known, having a cancer diagnosis and the likelihood of an incoming operation during the weeks after diagnosis, place patients in a situation where they may be more receptive to adopting lifestyle changes aimed at promoting health. Such changes could be incorporated, not just in the short-term in preparation for surgery, but also in the medium- and long-term, improving patients' wellbeing and potentially reducing the risk of cancer reoccurrence and other diseases.
Although the benefits of prehabilitation before surgery are understood, the effects it may have in non-insulin-dependent Type 2 diabetes patients are unknown.
This project aims to: (i) Analyse the effects of a multimodal prehabilitation programme vs. the current National Health Service (NHS) standard approach, on physical performance in cancer patients with non-insulin-dependent Type 2 diabetes prior to surgery. (ii) Explore the impact of the programme on body composition and metabolic markers. (iii) Analyse the programme adherence, markers of well-being and quality of life during a post-surgery period of up to 12 months as well as its effects on clinical outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will take advantage of already existing infrastructures, by approaching a single National Health Service (NHS) hospital in England that is already run a prehabilitation service for its patients. This study will analyse the effect of the prehabilitation programme on a specific group of patients, those with cancer and Type 2 diabetes who do not require insulin as part of their diabetes treatment and who are waiting for surgery.
Surgical prehabilitation refers to interventions done before surgery to increase the patient's overall health and fitness so that they can better cope with the stress of surgery, avoid complications/reduce, and have a faster recovery after surgery. Multimodal prehabilitation combines different aspects related to a healthy lifestyle, including but not limited to; physical activity, nutritional education, anxiety coping strategies, alcohol moderation and smoking cessation.
Multimodal prehabilitation programmes may use a combination of telehealth and face-to-face delivery to provide flexibility according to the preferences of the patients.
The collaboration between the University of Greenwich and NHS will provide an opportunity to measure the impact of the programme on those participants with Type 2 diabetes, beyond variables like weight and fasting blood glucose (i.e., body composition, glycaemic behaviour, blood insulin concentration, immune system markers…).
The hospital prehabilitation team will identify potential study participants (patients with Type 2 diabetes who do not use insulin awaiting surgery) amongst those referred to their service. The prehabilitation team will present the idea of the study to the potential participants and will ask for consent to share their contact details with the sponsor. If consent is received, the researcher will contact them to briefly present to them the possibility of joining the study. This 1st contact will be overseen by the Chief Investigator.
Those who accept to participate in the study will be allocated into 2 different groups. Patients undergoing prehabilitation will join the prehabilitation group of the study, while those declining prehabilitation will join the control group.
Regardless of the group, all patients will undergo the same number of interactions with the researcher:
- Interview and consent The candidate will be provided with the patient information sheet and explained what they can expect and what will be expected from them if they decide to participate in the study. Candidates will be able to ask questions and, in case they decide to participate, they will sign the participant consent form.
Baseline/initial assessment The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers.
This assessment will take place a few weeks before surgery before the patient starts prehabilitation (prehab group) or upon joining the study (control group).
Assessment before surgery The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers.
This assessment will take place a few days before surgery.
Assessment 6 weeks after surgery The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers.
This assessment will take place 6 weeks after surgery, a time that generally allows the participant to recover enough to be able to move around comfortably and perform some light physical activity
Assessment 6 months after surgery The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers.
This assessment will take place 6 months after surgery, a time by which the patient will generally be fully recovered, potentially reaching their pre-surgical status, and will have been able to resume their regular day-to-day activity
- Assessment 12 months after surgery The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers.
Both groups (prehabilitation and control) will undergo the same previously described assessments. This will allow us to understand and compare how the measured variables change through time in both groups (prehabilitation vs control).
The investigators hypothesise that prehabilitation will improve patients' physical performance prior to surgery and will provide them with a range of tools to help them recover faster and manage their overall health better (including their diabetes control) for at least one year after surgery.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Fernando Naclerio, PhD
- Phone Number: 0044 2083 318441
- Email: f.j.naclerio@greenwich.ac.uk
Study Contact Backup
- Name: Roberto Laza-Cagigas, MSc
- Phone Number: 0044 7597 058406
- Email: r.lazacagigas@greenwich.ac.uk
Study Locations
-
-
England
-
Eltham, England, United Kingdom, SE9 2BT
- School of Human Sciences, University of Greenwich, Avery Hill Campus, Sparrows Farm (Office SF112B)
-
Contact:
- Fernando Naclerio, PhD
- Phone Number: 0044 2083 318441
- Email: f.j.naclerio@greenwich.ac.uk
-
Contact:
- Roberto Laza-Cagigas, MSc
- Phone Number: 0044 7597 058406
- Email: r.lazacagigas@greenwich.ac.uk
-
Sub-Investigator:
- Roberto Laza-Cagigas, PhD
-
Sub-Investigator:
- Ian Swaine, PhD
-
Sub-Investigator:
- Marcos Seijo, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Capacity to give consent
- Newly diagnosed with cancer
- Non-insulin-dependent Type 2 diabetes
- Awaiting surgery for cancer
Exclusion Criteria:
- Medical contraindication to engage in physical activity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Prehabilitation
Arm undergoing multimodal prehabilitation (physical activity, nutritional education and anxiety management) during the weeks leading up to surgery
|
Participants will be encouraged to engage in regular physical activity (endurance and resistance exercise), eat healthily and undergo cognitive behavioural therapy (the latter only if required) during the weeks prior to surgery.
|
No Intervention: Standard of care
Arm receiving standard of care (no prehabilitation)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Short Physical Performance Battery (SPPB) at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Group of measures that combines the results of the gait speed, chair stand and balance tests, with scores ranging from 0 (worst performance) to 12 (best performance).
|
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in fasting glucose at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Blood fasting glucose obtained via finger prick
|
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Changes in fasting insulin at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Blood fasting insulin obtained via finger prick
|
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Changes in BMI at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Body mass index
|
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Changes in waist circumference at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Waist circumference
|
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Changes in hip circumference at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Hip circumferences
|
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Changes in Patient Health Questionnaire-9 (PHQ-9) at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Self-administered questionnaires to assess depression severity, with scores ranging from 0 (no depression) to 27 (severe depression)
|
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospital length of stay
Time Frame: 8 weeks after surgery
|
Number of days spent in the hospital after surgery
|
8 weeks after surgery
|
90-day readmission
Time Frame: 90 days after surgery
|
Number of readmissions during the 90 days after surgery
|
90 days after surgery
|
Postsurgical complications
Time Frame: 6 months after surgery
|
Number of complications after surgery
|
6 months after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Fernando Naclerio, PhD, University of Greenwich
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UoG_2022_CT2D_Prehab
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
Clinical Trials on Multimodal surgical prehabilitation
-
Tongji HospitalRecruitingSurgery | Non Small Cell Lung Cancer | Cardiorespiratory Fitness | PrehabilitationChina
-
Hospital Clinic of BarcelonaRecruiting
-
Hospital Clinic of BarcelonaRecruitingPancreatic Neoplasms | AnesthesiaSpain
-
Universidad del RosarioHospital Universitario Mayor MederiRecruitingOlder People | Prehabilitation | Surgical ProcedureColombia
-
IRCCS San RaffaeleMinistry of Health, ItalyRecruitingPancreatic Cancer | Malnutrition | Periampullary Cancer | Frailty Syndrome | Perioperative/Postoperative ComplicationsItaly
-
Parc de Salut MarRecruiting
-
University Hospital Inselspital, BerneUniversity of BernRecruitingFrail Elderly Syndrome | Major SurgerySwitzerland
-
University Health Network, TorontoMOUNT SINAI HOSPITALCompletedOsteosarcoma | Sarcoma,Soft TissueCanada
-
McGill University Health Centre/Research Institute...Society of American Gastrointestinal and Endoscopic Surgeons; Immunotec Inc.CompletedColorectal Cancer | Colorectal Cancer Stage IIICanada
-
Gérond'ifRecruitingOsteoarthritis | GonarthrosisFrance